@article{a37fb757d1c24df49a21581b1ce3824b,
title = "Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies - Perspectives from the American Society of Onco-Nephrology (ASON)",
keywords = "CKD, cancer, chemotherapy, clinical trial, cockcroft-gault, creatinine, drug metabolism, drug nephrotoxicity, kidney cancer, onconephrology",
author = "Abhijat Kitchlu and Silva, \{Ver{\^o}nica T.Costa E.\} and Shuchi Anand and Jaya Kala and Ala Abudayyeh and Inker, \{Lesley A.\} and Rosner, \{Mitchell H.\} and Sabine Karam and Prakash Gudsoorkar and Shruti Gupta and Sheldon Chen and Nattawat Klomjit and Nelson Leung and Tomaz Milanez and Motwani, \{Shveta S.\} and Khalid, \{Sheikh B.\} and Vinay Srinivasan and Rimda Wanchoo and Beumer, \{Jan H.\} and Geoffrey Liu and Tannir, \{Nizar M.\} and Ani Orchanian-Cheff and Yimin Geng and Herrmann, \{Sandra M.\}",
year = "2024",
month = aug,
doi = "10.2215/CJN.0000000000000509",
language = "English (US)",
volume = "19",
pages = "1073--1077",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "Lippincott Williams and Wilkins",
number = "8",
}
